COVID-19 MALAYSIA Kementerian Kesihatan Malaysia

APA YANG PERLU DILAKUKAN SEKIRANYA MENGALAMI AEFI SERIUS

Bahagian Regulatori Farmasi Negara (NPRA) sentiasa memantau risiko keselamatan semua vaksin berdaftar yang digunakan di Malaysia termasuk vaksin COVID-19 melalui pemantauan laporan Kesan Advers Susulan Imunisasi (AEFI). Penerima vakisn yang mengalami kesan advers perlu melaporkan AEFI melalui saluran yang telah disediakan.

20220212-aefi-serius-BM


The National Pharmaceutical Regulatory Agency (NPRA) constantly monitors the safety risks of all registered vaccines used in Malaysia including COVID-19 vaccines through monitoring the Adverse Effects Following Immunisation (AEFI) report. Vaccine recipients experiencing adverse effects should report AEFI through the provided channels

20220212-aefi-serius-EN

Next Post Previous Post